These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 12430634

  • 21. Lymphoid tissue targeting of anti-HIV drugs using liposomes.
    Désormeaux A, Bergeron MG.
    Methods Enzymol; 2005; 391():330-51. PubMed ID: 15721390
    [Abstract] [Full Text] [Related]

  • 22. [Study on brain targeting 3',5'-dioctanoyl-5-fluoro-2'-deoxyuridine pharmacosomes].
    Zhang ZR, Wang JX.
    Yao Xue Xue Bao; 2001 Oct; 36(10):771-6. PubMed ID: 12579979
    [Abstract] [Full Text] [Related]

  • 23. Antibody targeting of doxorubicin-loaded liposomes suppresses the growth and metastatic spread of established human lung tumor xenografts in severe combined immunodeficient mice.
    Sugano M, Egilmez NK, Yokota SJ, Chen FA, Harding J, Huang SK, Bankert RB.
    Cancer Res; 2000 Dec 15; 60(24):6942-9. PubMed ID: 11156394
    [Abstract] [Full Text] [Related]

  • 24. Antitumoral activity of liposomes and immunoliposomes containing 5-fluorouridine prodrugs.
    Crosasso P, Brusa P, Dosio F, Arpicco S, Pacchioni D, Schuber F, Cattel L.
    J Pharm Sci; 1997 Jul 15; 86(7):832-9. PubMed ID: 9232525
    [Abstract] [Full Text] [Related]

  • 25. Effect of dipyridamole on fluorodeoxyuridine cytotoxicity in vitro and in cancer patients.
    Buzaid AC, Alberts DS, Einspahr J, Mosley K, Peng YM, Tutsch K, Spears CP, Garewal HS.
    Cancer Chemother Pharmacol; 1989 Jul 15; 25(2):124-30. PubMed ID: 2532072
    [Abstract] [Full Text] [Related]

  • 26. Sterically stabilized anti-G(M3), anti-Le(x) immunoliposomes: targeting to B16BL6, HRT-18 cancer cells.
    Nam SM, Kim HS, Ahn WS, Park YS.
    Oncol Res; 1999 Jul 15; 11(1):9-16. PubMed ID: 10451027
    [Abstract] [Full Text] [Related]

  • 27. Establishment and evaluation of cancer-specific human monoclonal antibody GAH for targeting chemotherapy using immunoliposomes.
    Hosokawa S, Tagawa T, Niki H, Hirakawa Y, Ito N, Nohga K, Nagaike K.
    Hybrid Hybridomics; 2004 Apr 15; 23(2):109-20. PubMed ID: 15165484
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Comparative studies of the preparation of immunoliposomes with the use of two bifunctional coupling agents and investigation of in vitro immunoliposome-target cell binding by cytofluorometry and electron microscopy.
    Schwendener RA, Trüb T, Schott H, Langhals H, Barth RF, Groscurth P, Hengartner H.
    Biochim Biophys Acta; 1990 Jul 09; 1026(1):69-79. PubMed ID: 2378882
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Enhanced growth inhibition and differentiation of fluorodeoxyuridine-treated human colon carcinoma cells by phenylbutyrate.
    Huang Y, Waxman S.
    Clin Cancer Res; 1998 Oct 09; 4(10):2503-9. PubMed ID: 9796984
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Investigation of the cellular uptake of E-Selectin-targeted immunoliposomes by activated human endothelial cells.
    Kessner S, Krause A, Rothe U, Bendas G.
    Biochim Biophys Acta; 2001 Oct 01; 1514(2):177-90. PubMed ID: 11557019
    [Abstract] [Full Text] [Related]

  • 35. Immunoliposomes.
    Paszko E, Senge MO.
    Curr Med Chem; 2012 Oct 01; 19(31):5239-77. PubMed ID: 22934774
    [Abstract] [Full Text] [Related]

  • 36. Cellular association and cytotoxicity of anti-CD74-targeted lipid drug-carriers in B lymphoma cells.
    Lundberg BB, Griffiths G, Hansen HJ.
    J Control Release; 2004 Jan 08; 94(1):155-61. PubMed ID: 14684279
    [Abstract] [Full Text] [Related]

  • 37. Sterically stabilized anti-idiotype immunoliposomes improve the therapeutic efficacy of doxorubicin in a murine B-cell lymphoma model.
    Tseng YL, Hong RL, Tao MH, Chang FH.
    Int J Cancer; 1999 Mar 01; 80(5):723-30. PubMed ID: 10048974
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Future directions of liposome- and immunoliposome-based cancer therapeutics.
    Park JW, Benz CC, Martin FJ.
    Semin Oncol; 2004 Dec 01; 31(6 Suppl 13):196-205. PubMed ID: 15717745
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.